Nagpur
08042755301
+919970006978

Keytruda Injection (Pembrolizumab 100mg) Exporter from India to USA, UK Paramount Global Trade

Keytruda Injection contains pembrolizumab and is supplied in a 100 mg/4 mL presentation. The FDA labeling identifies KEYTRUDA as a PD-1-blocking antibody with specific dosage and administration instructions, which makes accurate product representation and compliance essential in pharmaceutical trade content

Paramount Global Trade is a trusted pharmaceutical export company in India supplying Keytruda Injection (Pembrolizumab 100mg) to international buyers across the USA, UK, Australia, Singapore, and the Philippines. Keytruda is a pembrolizumab injection available in 100 mg/4 mL strength, and exporters typically present it with full product specifications, storage details, and compliant trade documentation.


We support B2B buyers, importers, distributors, and healthcare procurement teams looking for reliable oncology medicine supply from India. Our export process is designed for cross-border trade requirements, including professional communication, documentation support, and shipment coordination for regulated pharmaceutical markets.


What the medicine is

Keytruda Injection contains pembrolizumab, an immunotherapy medicine presented in a 100 mg/4 mL strength in FDA labeling references. It is a prescription medicine used in oncology, so product pages should describe it factually and avoid treatment claims beyond approved labeling.

Uses

Keytruda is used in cancer treatment under approved medical guidance, and the label identifies it as a PD-1-blocking antibody. For an export page, keep the wording general: β€œused in oncology treatment” or β€œused under prescription supervision” rather than making marketing claims.


Why Choose Paramount Global Trade

  • Indian pharmaceutical exporter for global markets.

  • B2B supply support for oncology medicines.

  • Export-oriented product documentation.

  • Responsive quotation and inquiry handling.

  • International market focus: USA, UK, Australia, Singapore, Philippines.

Export process

A typical pharmaceutical export process includes inquiry, quotation, order confirmation, documentation, quality review, packing, shipment, and customs-related coordination. For regulated medicines, permissions and country-specific rules may apply, so the page should mention that documents and compliance steps are handled as per destination-country requirements.

Countries supplied

You can list the destination markets you named as target supply regions: USA, UK, Australia, Singapore, and the Philippines. Since medicine import rules differ by country, it is safest to say β€œsupplied subject to regulatory and import compliance in the destination country”.

FAQ

Q1. Is Keytruda Injection available for export from India?
Yes, it can be presented as an export inquiry product, subject to availability and compliance requirements.

Q2. What strength is available?
The referenced presentation is Pembrolizumab 100 mg/4 mL

Q3. Which countries do you supply?
USA, UK, Australia, Singapore, and the Philippines, subject to destination-country rule

Q4. Can you share manufacturer details?
Yes, once verified from the source inventory or official documentation.


Ready to source Keytruda Injection (Pembrolizumab 100mg) from India? Contact us today for quick quotation, availability, and export support.
πŸ“§ Email: support@indiamedicineseller.com
🌐 Website: https://www.indiamedicineseller.com
πŸ“± WhatsApp: +91 99700 06978


 2026-06-29T13:54:02

Keywords